P35557 (HXK4_HUMAN) Homo sapiens (Human)

Hexokinase-4 UniProtKBInterProSTRINGInteractive Modelling

465 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3; ) Identical sequences: Homo sapiens: Q53Y25; Pan troglodytes: A0A2J8L9L4

Sequence Features

 4D -> N (in dbSNP:rs202091228). VAR_003692 dbSNP
 11A -> T (in dbSNP:rs116093166). VAR_010583 dbSNP
 16V -> E (in MODY2). VAR_079430
 19I -> N (in MODY2). VAR_079431
 20L -> P (in MODY2). VAR_079432
 36R -> W (in MODY2; dbSNP:rs762263694). VAR_010584 dbSNP
 40E -> K (in PNDM; decreased stability; decreased glucokinase activity; decreased affinity for glucose; dbSNP:rs794727236). VAR_079433 dbSNP
 43R -> C (in PNDM; decreased stability; decreased glucokinase activity; no effect on affinity for glucose; dbSNP:rs1486280029). VAR_079434 dbSNP
 43R -> H (in MODY2; unknown pathological significance; no change in glucokinase activity; dbSNP:rs764232985). VAR_075220 dbSNP
 43R -> S (in MODY2). VAR_079435
 44G -> S (in MODY2; dbSNP:rs267601516). VAR_079436 dbSNP
 50H -> D (in PNDM; loss of stability; loss of glucokinase activity; decreased affinity for glucose). VAR_079437
 53A -> S (in MODY2). VAR_010585
 61Y -> S (in MODY2; decreased glucokinase activity; decreased affinity for glucose; increased affinity for ATP). VAR_079439
 65T -> I (in HHF3; increased glucokinase activity based on measure of catalytic efficiency; increased affinity for glucose; loss of inhibition by GCKR; unchanged affinity for ATP). VAR_078243
 68G -> D (in MODY2; unknown pathological significance; mildly increases glucokinase activity; dbSNP:rs373418736). VAR_075221 dbSNP
 70E -> K (in MODY2; decreased affinity for glucose). VAR_003693
 72G -> R (in MODY2 and PNDM; decreased stability; no effect on glucokinase activity; no effect on affinity for glucose; dbSNP:rs193922289). VAR_079440 dbSNP
 77L -> P (in MODY2). VAR_079441
 78D -> E (in MODY2). VAR_079442
 80G -> A (in MODY2). VAR_003694
 80G -> D (in MODY2). VAR_079443
 80G -> S (in MODY2; dbSNP:rs1554335761). VAR_003695 dbSNP
 82T -> I (in MODY2). VAR_079444
 91V -> L (in HHF3; increased glucokinase activity; increased affinity for glucose). VAR_078244
 99W -> C (in HHF3; increased glucokinase activity; increased affinity for glucose; increased affinity for ATP). VAR_078245
 107M -> T. VAR_003696
 108Y -> H (in MODY2). VAR_010586
 110I -> T (in MODY2; dbSNP:rs1338970607). VAR_012352 dbSNP
 116T -> P (in MODY2). VAR_079445
 119A -> D (in MODY2; dbSNP:rs1176659689). VAR_012353 dbSNP
 129C -> Y (in MODY2). VAR_078246
 131S -> P (in MODY2; decreased affinity for glucose; dbSNP:rs104894010). VAR_003697 dbSNP
 137H -> R (in MODY2). VAR_010587
 150F -> S (in MODY2; dbSNP:rs193922297). VAR_010588 dbSNP
 151S -> T (in PNDM). VAR_079446
 152F -> L (in MODY2; unknown pathological significance). VAR_078247
 160D -> N (in MODY2; decreased glucokinase activity; decreased affinity for glucose; dbSNP:rs1554335566). VAR_079447 dbSNP
 164L -> P (in MODY2 and PNDM). VAR_012350
 168T -> A (in PNDM; decreased glucokinase activity; decreased affinity for glucose). VAR_079448
 168T -> P (in MODY2). VAR_010589
 169K -> R (in PNDM). VAR_079449
 175G -> R (in MODY2; dbSNP:rs587780344). VAR_003698 dbSNP
 182V -> L (in MODY2; decreased glucokinase activity; decreased affinity for glucose; increased affinity for ATP). VAR_079450
 182V -> M (in MODY2; dbSNP:rs587780345). VAR_003699 dbSNP
 187D -> Y (in MODY2). VAR_079452
 188A -> T (in MODY2; decreased affinity for glucose; dbSNP:rs751279776). VAR_003700 dbSNP
 188A -> V (in MODY2; dbSNP:rs193922307). VAR_078248 dbSNP
 191R -> W (in MODY2; dbSNP:rs1085307455). VAR_078249 dbSNP
 200V -> L (in MODY2). VAR_079453
 202M -> R (in MODY2). VAR_078250
 202M -> T (in MODY2; dbSNP:rs193922311). VAR_079454 dbSNP
 203V -> A (in MODY2). VAR_003701
 206T -> M (in MODY2; dbSNP:rs1441649062). VAR_079455 dbSNP
 209T -> M (in MODY2). VAR_010590
 210M -> K (in MODY2 and PNDM; dbSNP:rs80356654). VAR_012351 dbSNP
 210M -> T (in MODY2; dbSNP:rs80356654). VAR_010591 dbSNP
 213C -> R (in MODY2). VAR_010592
 214Y -> C (in HHF3; increased glucokinase activity based on measure of catalytic efficiency; increased affinity for glucose; decreased inhibition by GCKR; dbSNP:rs104894015). VAR_079456 dbSNP
 217D -> N (in MODY2; associated in cis with R-261 in some patients; mildly increased glucokinase activity; loss of glucokinase activity when associated with R-261; dbSNP:rs147065275). VAR_075222 dbSNP
 221E -> K (in MODY2; dbSNP:rs193922317). VAR_003702 dbSNP
 223G -> S (in MODY2). VAR_078251
 224M -> R (in MODY2). VAR_079457
 225I -> M (in MODY2; associated in cis with K-248; highly decreased glucokinase activity; loss of glucokinase activity when associated with K-248). VAR_075223
 226V -> M (in MODY2; no effect on stability; decreased glucokinase activity; decreased affinity for glucose; dbSNP:rs148311934). VAR_003703 dbSNP
 227G -> C (in MODY2). VAR_003704
 227G -> S (in MODY2). VAR_079458
 228T -> M (in MODY2 and PNDM; dbSNP:rs80356655). VAR_003705 dbSNP
 231N -> H (in MODY2; unknown pathological significance). VAR_078252
 233C -> R (in MODY2; loss of glucokinase activity; loss of affinity for glucose; loss of affinity for ATP). VAR_079459
 248E -> K (in MODY2; associated in cis with M-225; highly decreased glucokinase activity; loss of glucokinase activity when associated with M-225; dbSNP:rs759421263). VAR_075224 dbSNP
 252C -> G (in MODY2). VAR_079461
 255T -> A (in MODY2). VAR_079462
 256E -> K (in MODY2; dbSNP:rs769268803). VAR_003706 dbSNP
 257W -> R (in MODY2; almost complete loss of glucokinase activity; dbSNP:rs1554335135). VAR_003707 dbSNP
 259A -> T (in MODY2; dbSNP:rs1375656631). VAR_010593 dbSNP
 261G -> E (in MODY2). VAR_010594
 261G -> R (in MODY2 and PNDM; associated in cis with N-217 in some patients; highly decreased glucokinase activity; loss of glucokinase activity when associated with N-217; decreased affinity for glucose; dbSNP:rs104894008). VAR_003708 dbSNP
 265E -> K (in MODY2; decreased glucokinase activity; decreased affinity for glucose; no effect on affinity for ATP). VAR_079463
 279E -> Q (in MODY2; dbSNP:rs104894005). VAR_003709 dbSNP
 298M -> K (in MODY2). VAR_079464
 299G -> R (in MODY2; dbSNP:rs104894009). VAR_003710 dbSNP
 300E -> K (in MODY2; dbSNP:rs1255911887). VAR_003712 dbSNP
 300E -> Q (in MODY2). VAR_003711
 308R -> W (in MODY2). VAR_079465
 309L -> P (in MODY2). VAR_003713
 315L -> F (in MODY2; unknown pathological significance). VAR_078253
 336S -> L (in MODY2). VAR_010595
 342T -> P (in dbSNP:rs1000236360). VAR_066615 dbSNP
 367V -> M (in MODY2; dbSNP:rs1057521092). VAR_010596 dbSNP
 377R -> H (in MODY2; dbSNP:rs193922264). VAR_079466 dbSNP
 378A -> T (in MODY2; dbSNP:rs104894016). VAR_078254 dbSNP
 379A -> V (in MODY2; decreased glucokinase activity; decreased affinity for glucose; decreased affinity for ATP). VAR_079467
 382C -> Y (in MODY2). VAR_010597
 383S -> L (in MODY2; dbSNP:rs777870079). VAR_079468 dbSNP
 384A -> T (in MODY2; dbSNP:rs1376620210). VAR_010598 dbSNP
 385G -> V (in MODY2). VAR_012354
 392R -> C (in MODY2; dbSNP:rs1167124132). VAR_010599 dbSNP
 393M -> T (in PNDM; decreased stability; increased glucokinase activity; no effect on affinity for glucose). VAR_079469
 397R -> L (in PNDM; decreased stability; increased glucokinase activity; no effect on affinity for glucose; dbSNP:rs193929375). VAR_079470 dbSNP
 411S -> F (in MODY2). VAR_079472
 414K -> E (in MODY2; decreased affinity for glucose; dbSNP:rs193922272). VAR_003714 dbSNP
 416H -> P (in MODY2). VAR_079473
 420K -> E (in MODY2; no effect on glucokinase activity; decreased affinity for glucose; no effect on affinity for ATP). VAR_079474
 434C -> F (in MODY2; unknown pathological significance). VAR_078255
 441S -> L (in PNDM; decreased stability; decreased glucokinase activity; no effect on affinity for glucose; dbSNP:rs1286804191). VAR_079475 dbSNP
 441S -> W (in MODY2; decreased affinity for glucose). VAR_078256
 442E -> K (in HHF3; increased affinity for glucose; dbSNP:rs758737171). VAR_078257 dbSNP
 447R -> Q (in MODY2; dbSNP:rs1131691416). VAR_078258 dbSNP
 449A -> T (in PNDM; decreased stability; increased glucokinase activity; increased affinity for glucose; dbSNP:rs193922282). VAR_079476 dbSNP
 455V -> M (in HHF3; increased glucokinase activity based on measure of catalytic efficiency; increased affinity for glucose; decreased inhibition by GCKR; no effect on affinity for ATP; dbSNP:rs104894012). VAR_003715 dbSNP
 456A -> V (in HHF3; increased glucokinase activity based on measure of catalytic efficiency; increased affinity for glucose; loss of inhibition by GCKR; no effect on affinity for ATP; dbSNP:rs104894014). VAR_079477 dbSNP
 78-83ATP.
 295-296ATP.
 332-336ATP.
 411-415ATP.
 61-465Missing (in MODY2). VAR_079438
 186-465Missing (in MODY2 and NIDDM). VAR_079451
 234-465Missing (in MODY2). VAR_079460
 248-465Missing (in MODY2). VAR_081975
 360-465Missing (in MODY2). VAR_081976
 399-465Missing (in MODY2). VAR_079471
 16-215Hexokinase, N-terminal
IPR022672PF00349
 221-455Hexokinase, C-terminal
IPR022673PF03727

Sequence Alignments

Experimental structures

DescriptionOligo-stateLigandsStructureRangeDownloadAssess
Structural Basis for Regulation of Human Glucokinase by Glucokinase Regulatory Protein Heteromer
Q07071;
NA;F6P;4lc912-461
Crystal structure of Glucokinase in complex with compound 72monomer GLC;DMS;HKG;6e0i1-458
'Insights into Glucokinase Activation Mechanism: Observation of Multiple Distinct Protein Conform...monomer 4DC;IOD;GLC;4dch9-465
Human glucokinase in complex with novel activator (2S)-3-cyclohexyl-2-(6-fluoro-4-oxoquinazolin-3...monomer 1FW;GLC;IOD;4ise16-465
Human glucokinase in complex with novel activator (2S)-3-cyclohexyl-2-(6-fluoro-2,4-dioxo-1,4-dih...monomer IOD;GLC;1FX;4isf16-465
Human glucokinase in complex with novel activator (2S)-3-cyclohexyl-2-[4-(methylsulfonyl)-2-oxopi...monomer IOD;GLC;1FY;4isg16-465
Human glucokinase in complex with novel pyrazole activator.monomer IOD;GLC;8WJ;5v4x16-464
Human glucokinase in complex with novel indazole activator.monomer IOD;GLC;8WM;5v4w16-464
The structure of human glucokinase E339K mutationmonomer GOL;GLC;3qic12-459
Human pancreatic glucokinase in complex with glucose and activator showing a mobile flapmonomer GLC;MRK;3f9m12-458
Human Glucokinase in complex with a nanomolar activator.monomer 2N8;GLC;4no712-458
Glucokinase in complex with an activator and glucosemonomer NA;GLC;0H4;3vev12-458
Glucokinase in complex with glucose and activatormonomer NA;GLC;0H6;3vf612-458
Catalytic complex of Human Glucokinasemonomer MG;BGC;ANP;K;3fgu12-458
Glucokinase in complex with activator and glucosemonomer NA;GLC;S41;3s4112-458
Crystal structure of human glucokinase in complex with glucose and activatormonomer NA;GLC;S41;4dhy12-458
Crystal Structure of human glucokinase in complex with a synthetic activatormonomer NA;GLC;B84;3imx16-461
Human pancreatic glucokinase in complex with glucosemonomer K;GLC;3idh12-457
Human glucokinase in complex with a synthetic activatormonomer AJI;GLC;NA;3a0i16-461
glucokinase in complex with glucose and ATPgSmonomer NA;GLC;AGS;0H5;3vey16-461
Crystal structure of human glucokinasemonomer NA;GLC;MRK;1v4s16-461
Discovery of 2-Pyridyl Ureas as Glucokinase Activatorsmonomer GLC;3LZ;4rch16-461
'Ternary complex of human pancreatic glucokinase crystallized with activator, glucose and AMP-PNP'monomer MG;GLC;ANP;K;MRK;3id812-457
Human glucokinase in complex with a synthetic activatormonomer GLC;LOI;3goi16-461
Human Glucokinase in Complex with Novel Amino Thiazole Activatormonomer GLC;VO1;4mle16-461
Human glucokinase in complex with 2-amino benzamide activatormonomer NA;AJB;GLC;3fr016-461
Crystal structure of Glucokinase in complex with compound 6monomer GLC;HKM;6e0e16-461
Human Glucokinase in Complex with a Novel Amino Thiazole Allosteric Activatormonomer GLC;VO2;4mlh16-461
Crystal structure of human glucokinasemonomer NA;SO4;1v4t16-461
Crystal structure of Human Glucokinase in complex with a small molecule activator.monomer NA;GLC;1JD;4ixc15-459
Crystals structure of Human Glucokinase in complex with small molecule activatormonomer NA;GLC;1J9;4iwv15-459
Human glucokinase in complex with a synthetic activatormonomer NA;GLC;TK1;3h1v16-460
Crystal structure of glucokinase-activator complexmonomer GLC;926;4l3q16-460

Homology models built on isoform sequence

Isoform #Oligo-stateLigandsQMEANTemplateRangeSeq id (%)ReportDownloadAssess
2monomerAJB;GLC;-0.573fr0.1.A15-462
100.00
3monomer1J9;GLC;-0.164iwv.1.A12-458
99.12